Inhibition of NEDD8 and FAT10 ligase activities through the degrading enzyme NEDD8 ultimate buster 1: A potential anticancer approach (Review)
- Authors:
- Ka‑Liong Tan
- Francesco Pezzella
-
Affiliations: Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom - Published online on: October 6, 2016 https://doi.org/10.3892/ol.2016.5232
- Pages: 4287-4296
-
Copyright: © Tan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Ciechanover A: The ubiquitin-proteasome pathway: On protein death and cell life. EMBO J. 17:7151–7160. 1998. View Article : Google Scholar : PubMed/NCBI | |
Ciechanover A and Schwartz AL: The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death. Proc Natl Acad Sci USA. 95:2727–2730. 1998. View Article : Google Scholar : PubMed/NCBI | |
Hershko A: The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ. 12:1191–1197. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hershko A and Ciechanover A: The ubiquitin system. Annu Rev Biochem. 67:425–479. 1998. View Article : Google Scholar : PubMed/NCBI | |
Liu YC, Pan J, Zhang C, Fan W, Collinge M, Bender JR and Weissman SM: A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci USA. 96:4313–4318. 1999. View Article : Google Scholar : PubMed/NCBI | |
Gunawardena HP, Huang Y, Kenjale R, Wang H, Xie L and Chen X: Unambiguous characterization of site-specific phosphorylation of leucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-like receptor 4 (TLR4)-mediated signaling. J Biol Chem. 286:10897–10910. 2011. View Article : Google Scholar : PubMed/NCBI | |
Hochstrasser M: Origin and function of ubiquitin-like proteins. Nature. 458:422–429. 2009. View Article : Google Scholar : PubMed/NCBI | |
Bawa-Khalfe T and Yeh ET: SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression. Genes Cancer. 1:748–752. 2010. View Article : Google Scholar : PubMed/NCBI | |
Rao-Naik C, delaCruz W, Laplaza JM, Tan S, Callis J and Fisher AJ: The rub family of ubiquitin-like proteins. Crystal structure of Arabidopsis rub1 and expression of multiple rubs in Arabidopsis. J Biol Chem. 273:34976–34982. 1998. View Article : Google Scholar : PubMed/NCBI | |
Whitby FG, Xia G, Pickart CM and Hill CP: Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J Biol Chem. 273:34983–34991. 1998. View Article : Google Scholar : PubMed/NCBI | |
Kamitani T, Kito K, Nguyen HP and Yeh ET: Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem. 272:28557–28562. 1997. View Article : Google Scholar : PubMed/NCBI | |
Kim DY, Kwon E, Hartley PD, Crosby DC, Mann S, Krogan NJ and Gross JD: CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. Mol Cell. 49:632–644. 2013. View Article : Google Scholar : PubMed/NCBI | |
Hori T, Osaka F, Chiba T, Miyamoto C, Okabayashi K, Shimbara N, Kato S and Tanaka K: Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene. 18:6829–6834. 1999. View Article : Google Scholar : PubMed/NCBI | |
Salon C, Brambilla E, Brambilla C, Lantuejoul S, Gazzeri S and Eymin B: Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: Relationships with CAND1 and cyclin E protein levels. J Pathol. 213:303–310. 2007. View Article : Google Scholar : PubMed/NCBI | |
Chairatvit K and Ngamkitidechakul C: Control of cell proliferation via elevated NEDD8 conjugation in oral squamous cell carcinoma. Mol Cell Biochem. 306:163–169. 2007. View Article : Google Scholar : PubMed/NCBI | |
Raasi S, Schmidtke G and Groettrup M: The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem. 276:35334–35343. 2001. View Article : Google Scholar : PubMed/NCBI | |
Fan W, Cai W, Parimoo S, Schwarz DC, Lennon GG and Weissman SM: Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics. 44:97–103. 1996. View Article : Google Scholar : PubMed/NCBI | |
Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Tan S Yong, Kan A, Nuchprayoon I, Jin R, Lee KH, et al: Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene. 22:2592–2603. 2003. View Article : Google Scholar : PubMed/NCBI | |
Soucy TA, Dick LR, Smith PG, Milhollen MA and Brownell JE: The NEDD8 conjugation pathway and its relevance in cancer biology and therapy. Genes Cancer. 1:708–716. 2010. View Article : Google Scholar : PubMed/NCBI | |
Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, et al: Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med. 352:2487–2498. 2005. View Article : Google Scholar : PubMed/NCBI | |
San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS, et al: Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med. 359:906–917. 2008. View Article : Google Scholar : PubMed/NCBI | |
Kane RC, Dagher R, Farrell A, Ko CW, Sridhara R, Justice R and Pazdur R: Bortezomib for the treatment of mantle cell lymphoma. Clin Cancer Res. 13:5291–5294. 2007. View Article : Google Scholar : PubMed/NCBI | |
Yang Y, Kitagaki J, Dai RM, Tsai YC, Lorick KL, Ludwig RL, Pierre SA, Jensen JP, Davydov IV, Oberoi P, et al: Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 67:9472–9481. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zhao Y, Xiong X, Jia L and Sun Y: Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis. Cell Death Dis. 3:e3862012. View Article : Google Scholar : PubMed/NCBI | |
Kamitani T, Kito K, Fukuda-Kamitani T and Yeh ET: Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem. 276:46655–46660. 2001. View Article : Google Scholar : PubMed/NCBI | |
Kito K, Yeh ET and Kamitani T: NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J Biol Chem. 276:20603–20609. 2001. View Article : Google Scholar : PubMed/NCBI | |
Tanaka T, Kawashima H, Yeh ET and Kamitani T: Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J Biol Chem. 278:32905–32913. 2003. View Article : Google Scholar : PubMed/NCBI | |
Tanji K, Tanaka T and Kamitani T: Interaction of NUB1 with the proteasome subunit S5a. Biochem Biophys Res Commun. 337:116–120. 2005. View Article : Google Scholar : PubMed/NCBI | |
Groettrup M, Pelzer C, Schmidtke G and Hofmann K: Activating the ubiquitin family: UBA6 challenges the field. Trends Biochem Sci. 33:230–237. 2008. View Article : Google Scholar : PubMed/NCBI | |
Bornstein G, Ganoth D and Hershko A: Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate. Proc Natl Acad Sci USA. 103:11515–11520. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hosono T, Tanaka T, Tanji K, Nakatani T and Kamitani T: NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation. Br J Cancer. 102:873–882. 2010. View Article : Google Scholar : PubMed/NCBI | |
Lu B, Al-Ramahi I, Valencia A, Wang Q, Berenshteyn F, Yang H, Gallego-Flores T, Ichcho S, Lacoste A, Hild M, et al: Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance. Nat Neurosci. 16:562–570. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kanaya K, Sohocki MM and Kamitani T: Abolished interaction of NUB1 with mutant AIPL1 involved in Leber congenital amaurosis. Biochem Biophys Res Commun. 317:768–773. 2004. View Article : Google Scholar : PubMed/NCBI | |
Tanaka T, Nakatani T and Kamitani T: Inhibition of NEDD8-conjugation pathway by novel molecules: Potential approaches to anticancer therapy. Mol Oncol. 6:267–275. 2012. View Article : Google Scholar : PubMed/NCBI | |
Haas AL, Ahrens P, Bright PM and Ankel H: Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem. 262:11315–11323. 1987.PubMed/NCBI | |
Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, Mizushima N, Tanida I, Kominami E, Ohsumi M, et al: A ubiquitin-like system mediates protein lipidation. Nature. 408:488–492. 2000. View Article : Google Scholar : PubMed/NCBI | |
Rabut G and Peter M: Function and regulation of protein neddylation. ‘Protein modifications: Beyond the usual suspects’ review series. EMBO Rep. 9:969–976. 2008. View Article : Google Scholar : PubMed/NCBI | |
Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL Jr, Holton JM and Schulman BA: The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. Mol Cell. 12:1427–1437. 2003. View Article : Google Scholar : PubMed/NCBI | |
Leidecker O, Matic I, Mahata B, Pion E and Xirodimas DP: The ubiquitin E1 enzyme Ube1 mediates NEDD8 activation under diverse stress conditions. Cell cycle. 11:1142–1150. 2012. View Article : Google Scholar : PubMed/NCBI | |
Olsen SK, Capili AD, Lu X, Tan DS and Lima CD: Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature. 463:906–912. 2010. View Article : Google Scholar : PubMed/NCBI | |
Huang DT, Hunt HW, Zhuang M, Ohi MD, Holton JM and Schulman BA: Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity. Nature. 445:394–398. 2007. View Article : Google Scholar : PubMed/NCBI | |
Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, Scott DC, Borg LA, Neale G, Murray PJ, Roussel MF and Schulman BA: E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol Cell. 33:483–495. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kamura T, Conrad MN, Yan Q, Conaway RC and Conaway JW: The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev. 13:2928–2933. 1999. View Article : Google Scholar : PubMed/NCBI | |
Enchev RI, Schulman BA and Peter M: Protein neddylation: Beyond cullin-RING ligases. Nat Rev Mol Cell Biol. 16:30–44. 2015. View Article : Google Scholar : PubMed/NCBI | |
Hjerpe R, Thomas Y, Chen J, Zemla A, Curran S, Shpiro N, Dick LR and Kurz T: Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes. Biochem J. 441:927–936. 2012. View Article : Google Scholar : PubMed/NCBI | |
Saha A and Deshaies RJ: Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol Cell. 32:21–31. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chan Y, Yoon J, Wu JT, Kim HJ, Pan KT, Yim J and Chien CT: DEN1 deneddylates non-cullin proteins in vivo. J Cell Sci. 121:3218–3223. 2008. View Article : Google Scholar : PubMed/NCBI | |
Gong N, Li XY, Xiao Q and Wang YX: Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance. Anesthesiology. 120:962–975. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lyapina S, Cope G, Shevchenko A, Serino G, Tsuge T, Zhou C, Wolf DA, Wei N, Shevchenko A and Deshaies RJ: Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science. 292:1382–1385. 2001. View Article : Google Scholar : PubMed/NCBI | |
Mendoza HM, Shen LN, Botting C, Lewis A, Chen J, Ink B and Hay RT: NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J Biol Chem. 278:25637–25643. 2003. View Article : Google Scholar : PubMed/NCBI | |
Schwechheimer C, Serino G, Callis J, Crosby WL, Lyapina S, Deshaies RJ, Gray WM, Estelle M and Deng XW: Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIRI in mediating auxin response. Science. 292:1379–1382. 2001. View Article : Google Scholar : PubMed/NCBI | |
Goldenberg SJ, Cascio TC, Shumway SD, Garbutt KC, Liu J, Xiong Y and Zheng N: Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases. Cell. 119:517–528. 2004. View Article : Google Scholar : PubMed/NCBI | |
Liu J, Furukawa M, Matsumoto T and Xiong Y: NEDD8 modification of CUL1 dissociates p120 (CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases. Mol Cell. 10:1511–1518. 2002. View Article : Google Scholar : PubMed/NCBI | |
Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M and Schulman BA: Structural insights into NEDD8 activation of cullin-RING ligases: Conformational control of conjugation. Cell. 134:995–1006. 2008. View Article : Google Scholar : PubMed/NCBI | |
Morimoto M, Nishida T, Nagayama Y and Yasuda H: Nedd8-modification of Cul1 is promoted by Roc1 as a Nedd8-E3 ligase and regulates its stability. Biochem Biophys Res Commun. 301:392–398. 2003. View Article : Google Scholar : PubMed/NCBI | |
Osaka F, Kawasaki H, Aida N, Saeki M, Chiba T, Kawashima S, Tanaka K and Kato S: A new NEDD8-ligating system for cullin-4A. Genes Dev. 12:2263–2268. 1998. View Article : Google Scholar : PubMed/NCBI | |
Podust VN, Brownell JE, Gladysheva TB, Luo RS, Wang C, Coggins MB, Pierce JW, Lightcap ES and Chau V: A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci USA. 97:4579–4584. 2000. View Article : Google Scholar : PubMed/NCBI | |
Read MA, Brownell JE, Gladysheva TB, Hottelet M, Parent LA, Coggins MB, Pierce JW, Podust VN, Luo RS, Chau V and Palombella VJ: Nedd8 modification of cul-1 activates SCF (beta (TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol. 20:2326–2333. 2000. View Article : Google Scholar : PubMed/NCBI | |
Wada H, Yeh ET and Kamitani T: Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun. 257:100–105. 1999. View Article : Google Scholar : PubMed/NCBI | |
Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, et al: Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 44:325–340. 2011. View Article : Google Scholar : PubMed/NCBI | |
Jeram SM, Srikumar T, Zhang XD, Eisenhauer H Anne, Rogers R, Pedrioli PG, Matunis M and Raught B: An improved SUMmOn-based methodology for the identification of ubiquitin and ubiquitin-like protein conjugation sites identifies novel ubiquitin-like protein chain linkages. Proteomics. 10:254–265. 2010. View Article : Google Scholar : PubMed/NCBI | |
van der Veen AG and Ploegh HL: Ubiquitin-like proteins. Annu Rev Biochem. 81:323–357. 2012. View Article : Google Scholar : PubMed/NCBI | |
McLarnon A: Cancer: Mdm2-regulated stabilization of HuR by neddylation in HCC and colon cancer-a possible target for therapy. Nat Rev Gastroenterol Hepatol. 9:42011. View Article : Google Scholar | |
Ryu JH, Li SH, Park HS, Park JW, Lee B and Chun YS: Hypoxia-inducible factor alpha subunit stabilization by NEDD8 conjugation is reactive oxygen species-dependent. J Biol Chem. 286:6963–6970. 2011. View Article : Google Scholar : PubMed/NCBI | |
Freiberg RA, Hammond EM, Dorie MJ, Welford SM and Giaccia AJ: DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response. Mol Cell Biol. 26:1598–1609. 2006. View Article : Google Scholar : PubMed/NCBI | |
Ma T, Chen Y, Zhang F, Yang CY, Wang S and Yu X: RNF111-dependent neddylation activates DNA damage-induced ubiquitination. Mol Cell. 49:897–907. 2013. View Article : Google Scholar : PubMed/NCBI | |
Le Moan N, Houslay DM, Christian F, Houslay MD and Akassoglou K: Oxygen-dependent cleavage of the p75 neurotrophin receptor triggers stabilization of HIF-1α. Mol Cell. 44:476–490. 2011. View Article : Google Scholar : PubMed/NCBI | |
Pawlus MR, Wang L and Hu CJ: STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. 33:1670–1679. 2014. View Article : Google Scholar : PubMed/NCBI | |
Choo YS, Vogler G, Wang D, Kalvakuri S, Iliuk A, Tao WA, Bodmer R and Zhang Z: Regulation of parkin and PINK1 by neddylation. Hum Mol Genet. 21:2514–2523. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kandala S, Kim IM and Su H: Neddylation and deneddylation in cardiac biology. Am J Cardiovasc Dis. 4:140–158. 2014.PubMed/NCBI | |
Abida WM, Nikolaev A, Zhao W, Zhang W and Gu W: FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J Biol Chem. 282:1797–1804. 2007. View Article : Google Scholar : PubMed/NCBI | |
Noguchi K, Okumura F, Takahashi N, Kataoka A, Kamiyama T, Todo S and Hatakeyama S: TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers. Carcinogenesis. 32:995–1004. 2011. View Article : Google Scholar : PubMed/NCBI | |
Cao X and Sudhof TC: A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 293:115–120. 2001. View Article : Google Scholar : PubMed/NCBI | |
Lee MR, Lee D, Shin SK, Kim YH and Choi CY: Inhibition of APP intracellular domain (AICD) transcriptional activity via covalent conjugation with Nedd8. Biochem Biophys Res Commun. 366:976–981. 2008. View Article : Google Scholar : PubMed/NCBI | |
Theng SS, Wang W, Mah WC, Chan C, Zhuo J, Gao Y, Qin H, Lim L, Chong SS, Song J and Lee CG: Disruption of FAT10-MAD2 binding inhibits tumor progression. Proc Natl Acad Sci USA. 111:E5282–E5291. 2014. View Article : Google Scholar : PubMed/NCBI | |
Michel L, Diaz-Rodriguez E, Narayan G, Hernando E, Murty VV and Benezra R: Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proc Natl Acad Sci USA. 101:4459–4464. 2004. View Article : Google Scholar : PubMed/NCBI | |
Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D and Glatz K: Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol. 30:83–89. 2006. View Article : Google Scholar : PubMed/NCBI | |
Wagenaar-Miller RA, Gorden L and Matrisian LM: Matrix metalloproteinases in colorectal cancer: Is it worth talking about? Cancer Metastasis Rev. 23:119–135. 2004. View Article : Google Scholar : PubMed/NCBI | |
Aichem A, Kalveram B, Spinnenhirn V, Kluge K, Catone N, Johansen T and Groettrup M: The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation. J Cell Sci. 125:4576–4585. 2012. View Article : Google Scholar : PubMed/NCBI | |
Gao Y, Theng SS, Zhuo J, Teo WB, Ren J and Lee CG: FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells. Carcinogenesis. 35:923–934. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P, Breuhahn K and Groettrup M: Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene. 27:6068–6074. 2008. View Article : Google Scholar : PubMed/NCBI | |
Pelzer C, Kassner I, Matentzoglu K, Singh RK, Wollscheid HP, Scheffner M, Schmidtke G and Groettrup M: UBE1L2, a novel E1 enzyme specific for ubiquitin. J Biol Chem. 282:23010–23014. 2007. View Article : Google Scholar : PubMed/NCBI | |
Jin J, Li X, Gygi SP and Harper JW: Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature. 447:1135–1138. 2007. View Article : Google Scholar : PubMed/NCBI | |
Chiu YH, Sun Q and Chen ZJ: E1-L2 activates both ubiquitin and FAT10. Mol Cell. 27:1014–1023. 2007. View Article : Google Scholar : PubMed/NCBI | |
Aichem A, Pelzer C, Lukasiak S, Kalveram B, Sheppard PW, Rani N, Schmidtke G and Groettrup M: USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Nat Commun. 1:132010. View Article : Google Scholar : PubMed/NCBI | |
Hipp MS, Kalveram B, Raasi S, Groettrup M and Schmidtke G: FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol. 25:3483–3491. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hipp MS, Raasi S, Groettrup M and Schmidtke G: NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem. 279:16503–16510. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, Chong SS, Kon OL and Lee CG: FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem. 281:11413–11421. 2006. View Article : Google Scholar : PubMed/NCBI | |
Merbl Y, Refour P, Patel H, Springer M and Kirschner MW: Profiling of ubiquitin-like modifications reveals features of mitotic control. Cell. 152:1160–1172. 2013. View Article : Google Scholar : PubMed/NCBI | |
Gong P, Canaan A, Wang B, Leventhal J, Snyder A, Nair V, Cohen CD, Kretzler M, D'Agati V, Weissman S and Ross MJ: The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol. 21:316–326. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H and Johansen T: p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 171:603–614. 2005. View Article : Google Scholar : PubMed/NCBI |